French J F, Thomas C E, Downs T R, Ohlweiler D F, Carr A A, Dage R C
Marion Merrell Dow Research Institute, Cincinnati, OH 45215.
Circ Shock. 1994 Jul;43(3):130-6.
Evidence of a role for oxygen-derived free radicals in the pathophysiology of endotoxic shock has been found in animal models. However, the importance of free radicals in chronic models of bacterial infection has not been examined. In this study a novel nitrone radical spin trap is described and its activity in animal models of endotoxic shock and chronic bacteremia were explored. MDL 101,002 is a cyclized variant of alpha-phenyl N-tert-butyl nitrone (PBN), an established spin trap. MDL 101,002 can react with free radicals to form persistent adducts as demonstrated by electron paramagnetic resonance (EPR) spectroscopy. This agent is about 10 times more potent than PBN as an in vitro antioxidant and scavenger of hydroxyl radicals. In a rat endotoxic shock model MDL 101,002 (3-30 mg/kg, i.p.) administered 30 min prior to endotoxin (30 mg/kg, i.p.) treatment reduced mortality in a dose-dependent manner. Peroxide-enhanced chemiluminescence in hepatic homogenates from endotoxin treated rats was elevated indicating that oxidative stress and antioxidant depletion was increased. Importantly, treatment with MDL 101,002 (30 mg/kg, i.p.) 30 min prior to, and 120 min following endotoxin, minimized the increase in chemiluminescence. MDL 101,002 also reduced mortality in a model of chronic bacteremia employing implantation of infected fibrin clots into the peritoneal cavity of gentamicin-treated leukopenic rats. MDL 101,002 (2.5 mg/kg/hr) increased survival from 24% to 52% in these rats. These data are consistent with a role for free radicals in the pathophysiology of endotoxic shock and suggest free radicals are also important mediators in chronic models of sepsis.
在动物模型中已发现氧衍生自由基在内毒素休克病理生理学中起作用的证据。然而,自由基在细菌感染慢性模型中的重要性尚未得到研究。在本研究中,描述了一种新型硝酮自由基自旋捕获剂,并探讨了其在内毒素休克和慢性菌血症动物模型中的活性。MDL 101,002是已确立的自旋捕获剂α-苯基N-叔丁基硝酮(PBN)的环化变体。如电子顺磁共振(EPR)光谱所示,MDL 101,002可与自由基反应形成持久性加合物。作为体外抗氧化剂和羟基自由基清除剂,该试剂的效力约为PBN的10倍。在大鼠内毒素休克模型中,在内毒素(30 mg/kg,腹腔注射)治疗前30分钟给予MDL 101,002(3 - 30 mg/kg,腹腔注射)可剂量依赖性降低死亡率。内毒素处理大鼠肝脏匀浆中过氧化物增强的化学发光升高,表明氧化应激和抗氧化剂消耗增加。重要的是,在内毒素前30分钟和后120分钟用MDL 101,002(30 mg/kg,腹腔注射)处理,可使化学发光的增加最小化。MDL 101,002在将感染的纤维蛋白凝块植入庆大霉素处理的白细胞减少大鼠腹腔的慢性菌血症模型中也降低了死亡率。在这些大鼠中,MDL 101,002(2.5 mg/kg/小时)使存活率从24%提高到52%。这些数据与自由基在内毒素休克病理生理学中的作用一致,并表明自由基在脓毒症慢性模型中也是重要的介质。